284 related articles for article (PubMed ID: 26595692)
41. Long-term safety concerns with proton pump inhibitors.
Ali T; Roberts DN; Tierney WM
Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
[TBL] [Abstract][Full Text] [Related]
42. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
Mackay JD; Bladon PT
QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
[TBL] [Abstract][Full Text] [Related]
43. Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
Reiche I; Tröger U; Martens-Lobenhoffer J; Kandulski A; Neumann H; Malfertheiner P; Bode-Böger SM
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):880-2. PubMed ID: 19801940
[TBL] [Abstract][Full Text] [Related]
44. Drugs for peptic ulcer disease and GERD.
Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
[No Abstract] [Full Text] [Related]
45. Safety of long-term PPI therapy.
Reimer C
Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):443-54. PubMed ID: 23998981
[TBL] [Abstract][Full Text] [Related]
46. Proton pump inhibitor use in infants: FDA reviewer experience.
Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
[TBL] [Abstract][Full Text] [Related]
47. Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis.
Jiang YX; Chen Y; Kong X; Tong YL; Xu SC
Hepatogastroenterology; 2013; 60(125):1077-82. PubMed ID: 23803372
[TBL] [Abstract][Full Text] [Related]
48. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
49. Cardiovascular Risk of Proton Pump Inhibitors.
Ariel H; Cooke JP
Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
[TBL] [Abstract][Full Text] [Related]
50. Esomeprazole: a proton pump inhibitor.
Vachhani R; Olds G; Velanovich V
Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
[TBL] [Abstract][Full Text] [Related]
51. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
[TBL] [Abstract][Full Text] [Related]
52. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
[TBL] [Abstract][Full Text] [Related]
53. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
[No Abstract] [Full Text] [Related]
54. Proton pump inhibitors: balancing the benefits and potential fracture risks.
Richards JB; Goltzman D
CMAJ; 2008 Aug; 179(4):306-7. PubMed ID: 18695170
[No Abstract] [Full Text] [Related]
55. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
Huerta-Iga FM
Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
[No Abstract] [Full Text] [Related]
56. Proton pump inhibitors for irritable infants.
Smith CH; Israel DM; Schreiber R; Goldman RD
Can Fam Physician; 2013 Feb; 59(2):153-6. PubMed ID: 23418240
[TBL] [Abstract][Full Text] [Related]
57. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
Savarino V; Di Mario F; Scarpignato C
Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
[TBL] [Abstract][Full Text] [Related]
58. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.
Filion KB; Chateau D; Targownik LE; Gershon A; Durand M; Tamim H; Teare GF; Ravani P; Ernst P; Dormuth CR;
Gut; 2014 Apr; 63(4):552-8. PubMed ID: 23856153
[TBL] [Abstract][Full Text] [Related]
59. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
60. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB; Souza RF; Spechler SJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
